Physician profile
Albert V Chan
NPI 1386641744
$3,751.30
in general payments reported to CMS, 2019-2025
17 companies · $315 in 2025
The $315 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $845 · 2020: $205 · 2021: $435 · 2022: $344 · 2023: $668 · 2024: $940 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,923.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,922.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $806.21 | 2019-2024 | Mitraclip, Perclose Prostyle |
| E.R. Squibb & Sons, L.L.C. | $718.37 | 2019-2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $479.76 | 2019-2024 | Xarelto |
| Amgen INC. | $436.79 | 2019-2023 | Repatha |
| Novartis Pharmaceuticals Corporation | $385.58 | 2021-2024 | |
| Kestra Medical Technology Services, INC. | $301.83 | 2023-2024 | Assure Wcd |
| Heartflow, INC. | $168.05 | 2025 | |
| Scpharmaceuticals INC. | $133.63 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $92.80 | 2022-2025 | Lifevest |
| Boston Scientific Corporation | $82.29 | 2021 | |
| Abiomed | $43.39 | 2019 | |
| Pfizer INC. | $25.24 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.01 | 2019 | |
| Preventice Services, LLC | $15.57 | 2021 | |
| Portola Pharmaceuticals, LLC | $15.46 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $15.28 | 2019 | |
| Lundbeck LLC | $15.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.